The Hematron E.S.P.T. laboratory research device is designed to deliver a significant amount of wide spectrum photonic energy over a prolonged period of time via an energetic photonic infusion of the blood.  

The Hematron E.S.P.T. utilizes multiple light sources including a custom engineered enhanced spectrum, high energy light source, emitting wavelengths from 200nm (UVC) to 600 nm (well into the visible light range).   A second light source is a high output ‘U’ bulb of 254 nm which is enclosed in an individual reflective assembly. Further photonic energy is generated from   500+  high power LEDs, which emitted energy is   in the visible spectrum.  Research has shown these wavelengths to have specific, biological benefits. 

The reason that the Hematron is capable of delivering high energy to the blood without causing harm lies in its’  unique application and manipulation of the light energy striking the surface area.  The Hematron’s primary exposure time is 10 to 12 seconds; this takes place at three distinct intervals.  The secondary exposure takes place at six  diverse intervals, for a total exposure time between 25 and 30 seconds.  When a physician is presented with an acute condition such as H1N1 or West Niles virus, the amount of blood borne pathogens will be far greater than those seen in most chronic conditions.  Therefore, in acute cases, it is best to employ the full force of the Hematron and employ all light sources in the “ON” position.  Additional treatments are suggested to be a minimum of 12 hours apart.  

The Treatment:

  • Blood treated with the Hematron facilitates the following:
  • Renders virus and bacteria unable to replicate
  • Increased capabilities for oxygenation, by activating the 2,3, DPGenzyme system, which potentiates oxygen from the heme complex into the tissues
  • Enhances mitochondrial energy deficiencies
  • Stimulates lymphatic detoxification by restoration of functional chylomicron Brownian movement within the blood
  • Activates immune cells such as NK Cells, neutrophils, macrophages, and assists in the balancing of cytokine production..  This activation aids in the destruction of various microorganisms, fungi, viruses and bacteria.
  • Facilitates the destruction of cancer cells
  • Dismantles nagalase, which is a protein produced principally by cancer, viruses and some bacterium.  Nagalase disables the glycoprotein which is the basis for the body producing GCMAF. GCMAF is also a glycoprotein which binds to the macrophage and acts as a switch to turn on the macrophage function. It is also believed that it activatesmanyother cytotoxic immune cells such as NK cells.
  • Influences Zeta potential. Zeta potential refers to the free flowing component of RBCs.